Publications in 2025
Ng ABCD, Asif A, Agarwal R, Panebianco V, Girometti R, Ghai S, Gómez-Gómez E, Budäus L, Barrett T, Radtke JP, Kesch C, De Cobelli F, Pham T, Taneja SS, Hu JC, Tewari A, Cabello MAR, Dias AB, Mynderse LA, Borghi M, Boesen L, Singh P, Renard-Penna R, Leow JJ, Falkenbach F, Pecoraro M, Giannarini G, Perlis N, López-Ruiz D, Kastner C, Schimmöller L, Rossiter M, Nathan A, Khetrapal P, Chan VWS, Haider A, Clarke CS, Punwani S, Brew-Graves C, Dickinson L, Mitra A, Brembilla G, Margolis DJA, Takwoingi Y, Emberton M, Allen C, Giganti F, Moore CM, Kasivisvanathan V. Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis The PRIME Diagnostic Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025. 1170-1179. DOI:10.1001/jama.2025.13722. IF: 55 Q1 D1
Castillo LC, Belenchón IR, Sanz IP, Marenco RS, Claro AVO, Martínez NS, López RM, Soto AJ, Ossorio JLA, Galisteo EG, Valiente JC, Imbroda BH, Jiménez JM, Casas JAV, Rodríguez A, Ortiz AS, Hernández JPC, Gómez EG. Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence. PROSTATE. 2025. 1016-1023. DOI:10.1002/pros.24910. IF: 2,5 Q2 D4
Perez Montilla ME, García Jurado PB, Gómez Gómez E, Barranco Acosta S, Lombardo Galera MS, Campos Hernández PJ, Espejo Herrero JJ. Percutaneous ablation of renal tumors in patients with a solitary kidney: medium-to long-term outcomes. MINERVA UROLOGY AND NEPHROLOGY. 2025. 347-355. DOI:10.23736/S2724-6051.25.06010-0. IF: 4,2 Q1 D2
Frantzi M, Morillo AC, Lendinez G, Blanca A, Ruiz DL, Parada J, Heidegger I, Culig Z, Mavrogeorgis E, Beltran AL, Mora-Ortiz M, Carrasco-Valiente J, Mischak H, Medina RA, Hernandez PC, Gómez EG. Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI Pathway. PATHOBIOLOGY. 2025. 99-108. DOI:10.1159/000542465. IF: 2 Q2 D5
Canas-Marques R, Blanca A, Graça-Lopes R, Carvalho I, Pinto DG, Vasconcelos MA, Lopez-Beltran A, Fonseca I. Aberrant E-cadherin Expression in Lobular Carcinoma In Situ. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2025. 372-380. DOI:10.1097/PAS.0000000000002361. IF: 4,2 Q1 D1
Fatima Y, Jobre KN, Gomez-Gomez E, Malkiewicz B, Vlahou A, Mokou M, Mischak H, Frantzi M, Jankowski V. Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025. -. DOI:10.3390/ijms26157475. IF: 4,9 Q1 D3
Heidegger I, Frantzi M, Salcher S, Tymoszuk P, Martowicz A, Gomez-Gomez E, Blanca A, Cano GL, Latosinska A, Mischak H, Vlahou A, Langer C, Aigner F, Puhr M, Krogsdam A, Trajanoski Z, Wolf D, Pircher A. Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature. EUROPEAN UROLOGY ONCOLOGY. 2025. 652-662. DOI:10.1016/j.euo.2024.05.014. IF: 9,3 Q1 D1
Blanca A, Lopez-Beltran A, Gomez-Gomez E, Campos-Hernández P, Cimadamore A, Montironi R, Cheng L. Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer. PATHOBIOLOGY. 2025. 202-215. DOI:10.1159/000544733. IF: 2 Q2 D5
Rubio-Briones J, Borque-Fernando A, Escaño LME, Wong A, Cascales AG, Gómez EG, Fabra JMG, Sanguedolce F, Gomez-Veiga F, González PAL, Bello AP, Garcia NR, Semper MM, Novo JFS, Hajianfar R, Ciutat LLF, Alfaro AG, Ojeda JMD, Ariño AB, Dorado CQ, Iriarte AL, Fadrique GG, Bachs JMG, Barreras SG, Costa YP, Cabo AV, Aliaga MR, Perez FC, Servián P, Bortoló JMC, Delgado MS, de Ledesma JMR, Rodriguez CS, Abal VC, Martinez YEH, Imbroda BH, Dolezal P, Frau JG, Llorente PM, Jimenez JM, Uribe JSS, Ruiz CBC, Reyes A, Aparicio TF, Rodriguez JG, Sole MC, Segui AG, Bru JJP, de Castro JM, Moreno AM, Suárez JLM. Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results. CANCER MEDICINE. 2025. -. DOI:10.1002/cam4.71173. IF: 3,1 Q2 D5
Publications in 2024
Sáez-Martínez P, Porcel-Pastrana F, Montero-Hidalgo AJ, de la Haba SL, Sanchez-Sanchez R, González-Serrano T, Gómez-Gómez E, Martínez-Fuentes AJ, Jiménez-Vacas JM, Gahete MD, Luque RM. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. CANCER LETTERS. 2024. DOI: 10.1016/j.canlet.2023.216604. IF: 9,1 Q1 D2
Salguero J, Chamorro L, Gómez-Gómez E, Robles JE, Campos JP. Graft survival and delayed graft function with normothermic regional perfusion and rapid recovery after circulatory death in kidney transplantation: a propensity score matching study. MINERVA UROLOGY AND NEPHROLOGY. 2024. 60-67. DOI: 10.23736/S2724-6051.23.05393-4. IF: 4,9 Q1 D2
García-Morales L, Contreras-Matos FJ, Blanca-Pedregosa A, Mellado-Castillero A, Campos-Hernández JP, Lara MF, Puche-Sanz I, Gómez-Gómez E. Multi-Centre Study of Progression Factors and Intravesical Recurrence in Patients with Urothelial Carcinoma of the Upper Urinary Tract. DIAGNOSTICS. 2024. DOI: 10.3390/diagnostics14222491. IF: 3 Q1 D2
Montero-Hidalgo AJ, Jiménez-Vacas JM, Gómez-Gómez E, Porcel-Pastrana F, Sáez-Martinez P, Pérez-Gómez JM, Fuentes-Fayos AC, Blázquez-Encinas R, Sánchez-Sánchez R, González-Serrano T, Castro E, López-Soto PJ, Carrasco-Valiente J, Sarmento-Cabral A, Martinez-Fuentes AJ, Eyras E, Castaño JP, Sharp A, Olmos D, Gahete MD, Luque RM. SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer. SCIENCE ADVANCES. 2024. DOI: 10.1126/sciadv.ado8231. IF: 11,7 Q1 D1
Portugal-Gaspar F, Lopez-Beltran A, Paner GP, Blanca A, Gómez EG, Montironi R, Cimadamore A, Bilé A, Volavsek M, Cheng L. Giant cell carcinoma of the urinary bladder. VIRCHOWS ARCHIV. 2024. 535-546. DOI: 10.1007/s00428-024-03858-w. IF: 3,4 Q1 D3
Cimadamore A, Franzese C, DI Loreto C, Blanca A, Lopez-beltran A, Crestani A, Giannarini G, Tan PH, Carneiro BA, El-deiry WS, Montironi R, Cheng L. Predictive and prognostic biomarkers in urological tumours. PATHOLOGY. 2024. 228-238. DOI: 10.1016/j.pathol.2023.10.016. IF: 3,6 Q1 D3
Gómez-Gómez E, Martínez-Salamanca JI, Bianco F, Miles BJ, Burgos J, Quintas JJ, Cano-Castiñeira R, Gómez-Ferrer A, Rodríguez-Antolín A, Chéchile G, Fernández L, Martín A, Hidalgo P, Parramón M. ProsTAV, a clinically useful test in prostate cancer: an extension study. WORLD JOURNAL OF UROLOGY. 2024. DOI: 10.1007/s00345-024-05098-8. IF: 2,8 Q2 D3
Publications in 2023
Montero-Hidalgo AJ, Perez-Gomez JM, Martinez-Fuentes AJ, Gomez-Gomez E, Gahete MD, Jimenez-Vacas JM, Luque RM. Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment. WILEY INTERDISCIPLINARY REVIEWS-RNA. 2023. DOI: 10.1002/wrna.1760. IF: 7,3 Q1 D3
Salguero J, Chamorro L, Gómez-Gómez E, de Benito P, Robles JE, Campos JP. Kidney Survival Impact of Delayed Graft Function Depends on Kidney Donor Risk Index: A Single-Center Cohort Study. JOURNAL OF CLINICAL MEDICINE. 2023. DOI: 10.3390/jcm12196397. IF: 3,9 Q2 D4
Castillero AM, Morales LG, Gomez EG, Hernandez JPC. Management of Penis Fracture: Clinical Cases Treated in Our Center and Comparison with Literature. ARCHIVOS ESPANOLES DE UROLOGIA. 2023. 363-368. DOI: 10.56434/j.arch.esp.urol.20237605.43. IF: 0,5 Q4 D
Salguero J, Chamorro L, Gomez-Gomez E, Robles JE, Campos JP. Midterm Outcomes of Kidney Transplantation from Expanded Criteria Donors After Circulatory Death: A Single-Center Retrospective Cohort Study. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2023. 481-486. DOI: 10.6002/ect.2023.0076. IF: 0,9 Q4 D
Gómez-Dueñas G, Durán M, Calleja-Lozano R, Arjona-Sánchez A, Sánchez-Hidalgo JM, Rodríguez-Ortiza L, Ayllón-Terán MD, Campos-Hernández JP, Rodríguez-Benot A, Briceño J. Normothermic Regional Perfusion in Controlled Donation After Circulatory Determination of Death Simultaneous Pancreas - Kidney Transplantation. TRANSPLANTATION PROCEEDINGS. 2023. 2259-2261. DOI: 10.1016/j.transproceed.2023.09.007. IF: 0,9 Q4 D
Castillo LC, Morales LG, Lopez DR, Segura JS, Rosa JV, Curado FJA, Quesada JM, Pedregosa AB, Valiente JC, Gomez EG. The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice. PROSTATE. 2023. 765-772. DOI: 10.1002/pros.24515. IF: 2,8 Q2 D5
Jimenez-Vacas JM, Montero-Hidalgo AJ, Gomez-Gomez E, Saez-Martinez P, Fuentes-Fayos AC, Closa A, Gonzalez-Serrano T, Martinez-Lopez A, Sanchez-Sanchez R, Lopez-Casas PP, Sarmento-Cabral A, Olmos D, Eyras E, Castano JP, Gahete MD, Luque RM. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. TRANSLATIONAL RESEARCH. 2023. 68-79. DOI: 10.1016/j.trsl.2022.08.016. IF: 7,8 Q1 D2
Puigvert-Martinez AM, Prieto-Castro R, Artigas-Feliu R, Illan-Mateo P, Cruz-Culebra N, Gonzalez-Ayala G. An observational, national and multicentric study to describe the detection, diagnosis and treatment of erectile dysfunction and premature ejaculation from the patient's perspective. REVISTA INTERNACIONAL DE ANDROLOGIA. 2023. DOI: 10.1016/j.androl.2022.02.001. IF: 0,8 Q4 D
Bile-Silva A, Lopez-Beltran A, Blanca A, Lopez-Rios F, Gomez-Gomez E, Cimadamore A, Montironi R, Vau N, Cheng L. Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward. EXPERT OPINION ON BIOLOGICAL THERAPY. 2023. 407-418. DOI: 10.1080/14712598.2023.2201371. IF: 4,6 Q2 D3
Gaya JM, Territo A, Woldu S, Schwartzmann I, Verri P, Gonzalez-Perez L, Cozar JM, Minana B, Medina RA, de la Rosa-Kehrmann F, Lozano-Palacio F, Ribal MJ, Hernandez C, Castineiras JJ, Requena MJ, Moreno J, Caraballido JA, Baena V, Breda A, Redorta JP. Incidental diagnosis of bladder cancer in a national observational study in Spain. ACTAS UROLOGICAS ESPANOLAS. 2023. 296-302. DOI: 10.1016/j.acuro.2022.09.002. IF: 1,1 Q4 D
Frantzi M, Culig Z, Heidegger I, Mokou M, Latosinska A, Roesch MC, Merseburger AS, Makridakis M, Vlahou A, Blanca-Pedregosa A, Carrasco-Valiente J, Mischak H, Gomez-Gomez E. Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination. CANCERS. 2023. DOI: 10.3390/cancers15041166. IF: 5,2 Q2 D3
Bile-Silva A, Lopez-Beltran A, Rasteiro H, Vau N, Blanca A, Gomez E, Gaspar F, Cheng L. Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes. VIRCHOWS ARCHIV. 2023. 493-505. DOI: 10.1007/s00428-022-03481-7. IF: 3,5 Q2 D4
Puche-Sanz I, Chiu P, Morillo AC, Gomez-Gomez E. Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis. CURRENT OPINION IN UROLOGY. 2023. 472-481. DOI: 10.1097/MOU.0000000000001132. IF: 2,5 Q3 D
Blanca A, Lopez-Beltran A, Lopez-Porcheron K, Gomez-Gomez E, Cimadamore A, Bile-Silva A, Gogna R, Montironi R, Cheng L. Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype. CANCERS. 2023. DOI: 10.3390/cancers15072149. IF: 5,2 Q2 D3
Publications in 2022
Campos-Rodriguez F, Santos-Morano J, Jurado-Gamez B, Osman-Garcia I, Rivera-Munoz F, Salguero J, Manas-Escorza PM, Almeida-Gonzalez CV. SLEEP MEDICINE. 2022. DOI: 10.1016/j.sleep.2022.02.007
Herrero-Aguayo V, Saez-Martinez P, Jimenez-Vacas JM, Moreno-Montilla MT, Montero-Hidalgo AJ, Perez-Gomez JM, Lopez-Canovas JL, Porcel-Pastrana F, Carrasco-Valiente J, Anglada FJ, Gomez-Gomez E, Yubero-Serrano EM, Ibanez-Costa A, Herrera-Martinez AD, Sarmento-Cabral A, Gahete MD, Luque RM. MOLECULAR THERAPY-NUCLEIC ACIDS. 2022. DOI: 10.1016/j.omtn.2022.02.010
Castillero AM, Gomez EG, Hernandez JPC, Castro RP. ARCHIVOS ESPANOLES DE UROLOGIA. 2022. DOI: 10.56434/j.arch.esp.urol.20227506.86
Gomez EG, Sanz IP, Rosa JV, Valiente JC, Hernandez JPC, Curado FJA. ARCHIVOS ESPANOLES DE UROLOGIA. 2022
Martinez MD, Lozano RC, Arjona-Sanchez A, Sanchez-Hidalgo JM, Teran MDA, Rodriguez-Ortiz L, Hernandez PC, Rodriguez-Benot A, Delgado JB. TRANSPLANTATION PROCEEDINGS. 2022. DOI: 10.1016/j.transproceed.2022.09.014
Saez-Martinez P, Porcel-Pastrana F, Perez-Gomez JM, Pedraza-Arevalo S, Gomez-Gomez E, Jimenez-Vacas JM, Gahete MD, Luque RM. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022. DOI: 10.3390/ijms232113003
Lopez-Beltran A, Blanca A, Cimadamore A, Montironi R, Luque RJ, Volavsek M, Cheng L. VIRCHOWS ARCHIV. 2022. DOI: 10.1007/s00428-021-03264-6
Frantzi M, Heidegger I, Roesch MC, Gomez-Gomez E, Steiner E, Vlahou A, Mullen W, Guler I, Merseburger AS, Mischak H, Culig Z. WORLD JOURNAL OF UROLOGY. 2022. DOI: 10.1007/s00345-022-04077-1
Publications in 2021
Gomez-Gomez E, Sorribas SM, Valero-Rosa J, Blanca A, Mesa J, Salguero J, Carrasco-Valiente J, Lopez-Ruiz D, Anglada-Curado FJ. Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?. DIAGNOSTICS. 202 11(8):-. DOI: 10.3390/diagnostics11081335.
IF: 3,706 Q2 D3
Salguero J, Gomez-Gomez E, Valero-Rosa J, Carrasco-Valiente J, Mesa J, Martin C, Campos-Hernandez JP, Rubio JM, Lopez D, Requena MJ. Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance. KOREAN JOURNAL OF RADIOLOGY. 2021. 22(4):559-567. DOI: 10.3348/kjr.2020.085
IF: 3,5 Q2 D4
Galisteo JMR, Fernandez L, Gomez EG, de Pedro N, Castineira RC, Pedregosa AB, Guler I, Valiente JC, Esteban L, Gonzalez S, Castello N, Otero L, Garcia J, Segovia E, Tapia MJR, Najarro P. Telomere-based risk models for the early diagnosis of clinically significant prostate cancer. PROSTATE CANCER AND PROSTATIC DISEASES. 2021. 24(1):88-95. DOI: 10.1038/s41391-020-0232-4.
IF: 5,554 Q1 D2
Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Saez-Martinez P, Gomez-Gomez E, Leon-Gonzalez AJ, Fuentes-Fayos AC, Yubero-Serrano EM, Requena-Tapia MJ, Lopez M, Castano JP, Gahete MD, Luque RM. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 202 106(2):E696-E710. DOI: 10.1210/clinem/dgaa877.
IF: 5,958 Q1 D2
Leon-Gonzalez AJ, Saez-Martinez P, Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gomez-Gomez E, Madrona A, Castano JP, Espartero JL, Gahete MD, Luque RM. Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells. ANTIOXIDANTS. 2021. 10(9):-. DOI: 10.3390/antiox10091348.
IF: 6,312 Q1 D1
Jimenez-Vacas JM, Montero-Hidalgo AJ, Gomez-Gomez E, Fuentes-Fayos AC, Ruiz-Pino F, Guler I, Camargo A, Anglada FJ, Carrasco-Valiente J, Tena-Sempere M, Sarmento-Cabral A, Castano JP, Gahete MD, Luque RM. In 1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2021. 106(12):E4956-E4968. DOI: 10.1210/clinem/dgab516.
IF: 5,958 Q1 D2
Herrero-Aguayo V, Jimenez-Vacas JM, Saez-Martinez P, Gomez-Gomez E, Lopez-Canovas JL, Garrido-Sanchez L, Herrera-Martinez AD, Garcia-Bermejo L, Macias-Gonzalez M, Lopez-Miranda J, Castano JP, Gahete MD, Luque RM. Influence of Obesity in the miRNome: miR-4454, a Key Regulator of Insulin Response Via Splicing Modulation in Prostate. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2021. 106(2):E469-E48 DOI: 10.1210/clinem/dgaa580.
IF: 5,958 Q1 D2
Shah TT, Reddy D, Peters M, Ball D, Kim NH, Gomez EG, Miah S, Evans DE, Guillaumier S, van Rossum PSN, Van Son MJ, Hosking-Jervis F, Dudderidge T, Hindley R, Emara A, McCracken S, Greene D, Nigam R, McCartan N, Valerio M, Minhas S, Afzal N, Lewi H, Ogden C, Persad R, Virdi J, Moore CM, Arya M, Emberton M, Ahmed HU, Winkler M. Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study. PROSTATE CANCER AND PROSTATIC DISEASES. 2021. 24(2):567-574. DOI: 10.1038/s41391-020-00315-y.
IF: 5,554 Q1 D2
Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R. Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer. CANCERS. 2021. 13(1):-. DOI: 10.3390/cancers13010131.
IF: 6,639 Q1 D3
Lopez-Beltran A, Blanca A, Cimadamore A, Gogna R, Montironi R, Cheng L. Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis. CANCERS. 2021. 13(21):-. DOI: 10.3390/cancers13215500. IF: 6,639 Q1 D3
Sánchez Hidalgo, J.M., Durán Martínez, M., Calleja Lozano, R., Arjona Sánchez, Á., Ayllón Terán, M.D., Rodríguez Ortiz, L., Campos Hernández, P., Rodríguez Benot, A., Briceño Delgado, F.J. Influence of Donor and Recipient Sex Matching in Simultaneous Pancreas-Kidney Transplantation Outcomes (2021) Transplantation Proceedings, 53 (9), pp. 2688-2691. DOI: 10.1016/j.transproceed.2021.09.004
IF: 1.014 Q4
Lendínez-Cano, G., Ojeda-Claro, A.V., Gómez-Gómez, E., Morales Jimenez, P., Flores Martin, J., Dominguez, J.F., Amores, J., Cozar, J.M., Bachiller, J., Juárez, A., Linares, R., Garcia Galisteo, E., Alvarez Ossorio, J.L., Requena Tapia, M.J., Moreno Jimenez, J., Medina Lopez, R.A. Prospective study of diagnostic accuracy in the detection of high-grade prostate cancer in biopsy-naïve patients with clinical suspicion of prostate cancer who underwent the Select MDx test (2021) Prostate, 81 (12), pp. 857-865. DOI: 10.1002/pros.24182.
IF: 4.012 Q2
Publications in 2020
Monteiro-Reis S, Blanca A, Tedim-Moreira J, Carneiro I, Montezuma D, Monteiro P, Oliveira J, Antunes L, Henrique R, Lopez-Beltran A, Jeronimo C. A Multiplex Test Assessing MiR663a(me) and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (2):- DOI: 10.3390/jcm9020605
IF: 3,303 Q: 1
Segura JS, Rosa JV, Gomez EG, Cabello MDN, Garcia JR, Benot AR, Garcia JER, Tapia MJR, Hernandez JPC. A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant Surgical Aspects and Outcomes. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2020. 18 (2):149-152 DOI: 10.6002/ect.2019.0372
IF: 0,852 Q: 4
Lozano RC, Fernandez FJM, Lopez CAD, Tordera EMT, Valiente JC, Delgado FJB. A combined robotic approach to a synchronous upper rectal and prostate cancer - a video vignette. COLORECTAL DISEASE. 2020. 22 (12):2338-2339 DOI: 10.1111/codi.15274
IF: 2,769 Q: 2
Rolim I, Henriques V, Rolim N, Blanca A, Marques RC, Volavsek M, Carvalho I, Montironi R, Cimadamore A, Raspollini MR, Cheng L, Lopez-Beltran A. Clinicopathologic analysis of upper urinary tract carcinoma with variant histology. VIRCHOWS ARCHIV. 2020. 477 (1):111-120 DOI: 10.1007/s00428-020-02745-4
IF: 2,906 Q: 2
Lopez-Beltran A, Cheng L, Gevaert T, Blanca A, Cimadamore A, Santoni M, Massari F, Scarpelli M, Raspollini MR, Montironi R. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2020. 20 (2):231-243 DOI: 10.1080/14737159.2020.1699791
IF: 4,096 Q: 1
Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gomez-Gomez E, Fuentes-Fayos AC, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, Pedraza-Arevalo S, Gonzalez-Serrano T, Reyes O, Martinez-Lopez A, Sanchez-Sanchez R, Ventura S, Yubero-Serrano EM, R. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBIOMEDICINE. 2020. 51 ():- DOI: 10.1016/j.ebiom.2019.11.008
IF: 5,736 Q: 1
Puche-Sanz I, Sabio-Bonilla A, Sanchez-Conde V, Jimenez-Dominguez AC, Tamayo-Gomez A, Vila-Brana P, Vazquez-Alonso F, Rivas JG, Gomez-Gomez E, Campos-Juanatey F, Rodriguez JGO, Flores-Martin J, Moreno-Jimenez J, Cozar-Olmo JM. Emergency surgery during COVID-19 pandemia. ARCHIVOS ESPANOLES DE UROLOGIA. 2020. 73 (5):353-359
IF: 0,395 Q: 4
Prieto-Castro R, Puigvert-Martinez AM, Artigas-Feliu R, Illan-Mateo P, Cruz-Culebra N, Artes-Ferragud M. Opinions, Attitudes, and Perceptions in Relation to Erectile Dysfunction and Premature Ejaculation in the Undiagnosed Spanish Male Population. Results of the PANDORA Project. JOURNAL OF SEXUAL MEDICINE. 2020. 17 (8):1495-1508 DOI: 10.1016/j.jsxm.2020.04.381
IF: 3,293 Q: 2
Diaz-Reixa JLP, Gil BD, Coll E, Musquera M, Fernandez EG, Cabello R, Leon E, Parra L, Cuevas A, Anton B, Campos J. Renal transplantation during COVID-19 period in Spain. ARCHIVOS ESPANOLES DE UROLOGIA. 2020. 73 (5):447-454
IF: 0,395 Q: 4
Jose FG, Gonzalez JGA, Molina JMC, Arnau LB, Iribarren IM, Jabaloyas JMM, Rico FM, Garcia-Baquero R, Gaya MR, Garcia EL, Lopez CL, Castro RP, Salamanca JIM. SARS-CoV-2 infection: implications for sexual and reproductive health. A position statement of the Asociacion Espanola de Andrologia, Medicina Sexual y Reproductiva (ASESA). REVISTA INTERNACIONAL DE ANDROLOGIA. 2020. 18 (3):117-123 DOI: 10.1016/j.androl.2020.06.001
IF: 0,635 Q: 4
Saez-Martinez P, Jimenez-Vacas JM, Leon-Gonzalez AJ, Herrero-Aguayo V, Hidalgo AJM, Gomez-Gomez E, Sanchez-Sanchez R, Requena-Tapia MJ, Castano JP, Gahete MD, Luque RM. Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (6):- DOI: 10.3390/jcm9061703
IF: 3,303 Q: 1
Alvarez-Ossorio JL, Cozar-Olmo JM, Juarez-Soto A, Medina-Lopez R, Moreno-Jimenez J, Requena-Tapia MJ. Update of the Andalusian Association of Urology protocol for the management of metastatic castration-resistant prostate cancer. ACTAS UROLOGICAS ESPANOLAS. 2020. 44 (3):125-130 DOI: 10.1016/j.acuro.2019.09.001
IF: 0,873 Q: 4
Publications in 2019
Gomez-Gomez E, Jimenez-Vacas JM, Pedraza-Arevalo S, Lopez-Lopez F, Herrero-Aguayo V, Hormaechea-Agulla D, Valero-Rosa J, Ibanez-Costa A, Leon-Gonzalez AJ, Sanchez-Sanchez R, Gonzalez-Serrano T, Requena-Tapia MJ, Castano JP, Carrasco-Valiente J, Gahete MD, Luque RM. Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2019 Sep 6;8(9):1400. doi: 10.3390/jcm8091400.
IF: 5,688 D: 1
Jimenez-Vacas JM, Herrero-Aguayo V, Gomez-Gomez E, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, Fuentes-Fayos AC, Martinez-Lopez A, Sanchez-Sanchez R, Gonzalez-Serrano T, Lopez-Ruiz DJ, Requena-Tapia MJ, Castano JP, Gahete MD Luque RM. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. TRANSLATIONAL RESEARCH. 2019 Oct;212:89-103. doi: 10.1016/j.trsl.2019.07.001.
IF: 4,915 D: 1
Frantzi M, Gomez EG, Pedregosa AB, Rosa JV, Latosinska A, Culig Z, Merseburger AS, Luque RM, Tapia MJR, Mischak H, Valiente JC; CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer. BRITISH JOURNAL OF CANCER. 2019 Jun;120(12):1120-1128. doi: 10.1038/s41416-019-0472-z.
IF: 5,416 Q: 1
Gomez-Gomez E, Carrasco-Valiente J, Campos-Hernandez JP, Blanca-Pedregosa AM, Jimenez-Vacas JM, Ruiz-Garcia J, Valero-Rosa J, Luque RM, Requena-Tapia MJ; Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2019 Feb;23(2):934-942. doi: 10.1111/jcmm.13994.
IF: 4,658 Q: 1
Volavsek M, Henriques V, Blanca A, Montironi R, Cheng L, Raspollini MR, Cimadamore A, Vau N, Pierconti F, Lopez-Beltran A; Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples. VIRCHOWS ARCHIV. 2019 Dec;475(6):735-744. doi: 10.1007/s00428-019-02666-x.
IF: 2,868 Q: 2
Blanca A, Sanchez-Gonzalez A, Requena MJ, Carrasco-Valiente J, Gomez-Gomez E, Cheng L, Cimadamore A, Montironi R, Lopez-Beltran A; Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer. APMIS. 2019 Aug;127(8):545-553. doi: 10.1111/apm.12973.
IF: 2,225 Q: 2
Gomez Gomez E, Salamanca Bustos JJ, Carrasco Valiente J, Fernandez Rueda JL, Blanca A, Valero Rosa J, Bravo Arrebola I, Marquez López J, Jimenez Vacas JM, Luque R, Requena Tapia MJ. Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA. BMJ Open. 2019 Nov 12;9(11):e031032. doi: 10.1136/bmjopen-2019-031032.
IF: 2,376 Q: 2
Jiménez-Vacas JM, Gómez-Gómez E, Montero-Hidalgo AJ, Herrero-Aguayo V, L-López F, Sánchez-Sánchez R, Guler I, Blanca A, Méndez-Vidal MJ, Carrasco J, Lopez-Miranda J, Requena-Tapia MJ, Castaño JP, Gahete MD, Luque RM. Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer. J Clin Med. 2019 Nov 22;8(12):2056. doi: 10.3390/jcm8122056.
IF: 5,688 D: 1
Massari F, Nunno VD, Mollica V, Montironi R, Cheng L, Cimadamore A, Blanca A, Lopez-Beltran A. Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice. Immunotherapy. 2019 Dec;11(17):1507-1521. doi: 10.2217/imt-2019-0115.
IF: 3,028 Q: 3
Vau N, Henriques V, Cheng L, Blanca A, Fonseca J, Montironi R, Cimadamore A, Lopez-Beltran A. Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index nodule. Hum Pathol. 2019 Nov;93:6-15. doi: 10.1016/j.humpath.2019.08.012.
IF: 2,74 Q: 2
Publications in 2018
Gómez Gómez, E., Valero Rosa, J., Carrasco Valiente, J., Triviño Tarradas, F., Anglada Curado, F., López Ruiz, D., Requena Tapia, M.J. New Approach to Guide Target Prostate Biopsy: Technique and Initial Experience (2018) Urology, 121, pp. 198-199.
IF:2.3 Q: 2
Carrasco, J., Gómez, E., García, J.H., Valero, J., Sánchez, Á., Salamanca, J.J., Campos, J.P., Requena, M.J. Impact of the use of simulators on the mental workload and confidence in a digital rectal examination and bladder catheterization workshop [Article@Impacto del uso de simuladores sobre la carga mental y la confianza en un taller de tacto rectal y cateterizaciÓn vesical en estudiantes] (2018) Archivos Espanoles de Urologia, 71 (6), pp. 537-542.
Carrasco Valiente, J., Ruiz García, J.M., Requena Tapia, M.J. Oligometastatic prostate cancer. Concept and implications [Article@Cáncer de próstata oligometastásico. Concepto e implicaciones] (2018) Archivos Espanoles de Urologia, 71 (3), pp. 239-246.
Sánchez-Hidalgo, J.M., Salamanca-Bustos, J.J., Arjona-Sánchez, Á., Campos-Hernández, J.P., Ruiz Rabelo, J., Rodríguez-Benot, A., Requena-Tapia, M.J., Briceño-Delgado, J. What Is the Influence of Both Risk Donor and Risk Receiver on Simultaneous Pancreas-Kidney Transplantation? (2018) Transplantation Proceedings, 50 (2), pp. 664-668.
IF: 0.806 Q: 4
Salamanca-Bustos, J.J., Gomez-Gomez, E., Campos-Hernández, J.P., Carrasco-Valiente, J., Ruiz-García, J., Márquez-López, F.J., Zurera-Tendero, L., Requena-Tapia, M.J. Initial Experience in the Use of Novel Auto-expandable Metal Ureteral Stent in the Treatment of Ureter Stenosis in Kidney Transplanted Patients (2018) Transplantation Proceedings, 50 (2), pp. 587-590.
IF: 0.806 Q: 4
Gómez-Gómez, E., Jiménez-Vacas, J.M., Carrasco-Valiente, J., Herrero-Aguayo, V., Blanca-Pedregosa, A.M., León-González, A.J., Valero-Rosa, J., Fernández-Rueda, J.L., González-Serrano, T., López-Miranda, J., Gahete, M.D., Castaño, J.P., Requena-Tapia, M.J., Luque, R.M. Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer. (2018) Journal of Cellular and Molecular Medicine, 22 (11), pp. 5688-5697. Cited 1 time. DOI: 10.1111/jcmm.13845
IF: 4.302 Q: 1
Lopez-Beltran A, Henriques V, Cimadamore A, Santoni M, Cheng L, Gevaert T, Blanca A, Massari F, Scarpelli M, Montironi R. The Identification of Immunological Biomarkers in Kidney Cancers. FRONTIERS IN ONCOLOGY. 2018; 8: Núm artículo 456
IF: 4,416 Q: 2
Volavsek M, Blanca A, Montironi R, Cheng L, Raspollini MR, Vau N, Fonseca J, Pierconti F, Lopez-Beltran A. Digital versus light microscopy assessment of surgical margin status after radical prostatectomy. VIRCHOWS ARCHIV. 2018; 472(3):451-460.
IF: 2,936 Q: 2
Zamorano-Leon JJ, Segura A, Lahera V, Rodriguez-Pardo JM, Prieto R, Puigvert A, Farre AJL. Relationship Between Erectile Dysfunction, Diabetes and Dyslipidemia in Hypertensive-Treated Men. UROLOGY JOURNAL. 2018; 15(6):370-375.
IF: 0,88 Q: 4
Arjona-Sanchez A, Rodriguez-Ortiz L, Sanchez-Hidalgo JM, Rabelo JR, Salamanca-Bustos JJ, Rodriguez-Benot A, Campos-Hernandez P, Briceno-Delgado J. Intraoperative Heparinization During Simultaneous Pancreas-Kidney Transplantation: Is It Really Necessary?. TRANSPLANTATION PROCEEDINGS. 2018; 50(2):673-675.
IF: 0,806 Q: 4
Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Arjona-Sanchez A, Ruiz-Rabelo J, Salamanca-Bustos JJ, Rodriguez-Benot A, Marquez-Lopez FJ, Briceno-Delgado J. Pancreas Donor Hypernatremia: Is it Really a Risk Factor for Simultaneous Pancreas-kidney Transplantation?. TRANSPLANTATION PROCEEDINGS. 2018; 50(2):676-678.
IF: 0,806 Q: 4
Puigvert AM, Prieto R, Garcia F. Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities. REVISTA INTERNACIONAL DE ANDROLOGIA. 2018; 16(1):28-33.
IF: 0,096 Q: 4
